As TPX2 was identified as a hub gene among all group comparisons in WGCNA highlighting its central role for tumor progression, we examined the protein expression levels of TPX2 on a tissue microarray (TMA) containing 51 treatment naïve primary PCa samples with adjacent normal tissues and 35 matched lymph node metastases. This evidence concerns the gene TPX2 and posterior cortical atrophy.